Sign in
4

Changes in Ownership

AbbVie Inc. Filed Acc 0001179110-22-003077

Vice Chairman sold 200,000 shares at an average $154.25 ($30,849,488)

  • Vice Chairman acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SEVERINO MICHAEL · Vice Chairman

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Exercise or conversion : show line 1 in the form +70,879 $61.36 $4,349,135 222,982 D
2022-05-16 Exercise or conversion : show line 2 in the form +29,121 $79.02 $2,301,141 252,103 D
2022-05-16 Sale : show line 3 in the form −46,273 $154.04 $7,127,893 205,830 D
2022-05-16 Sale : show line 4 in the form −53,327 $154.80 $8,255,020 152,503 D
2022-05-16 Sale : show line 5 in the form −400 $155.44 $62,176 152,103 D
2022-05-17 Exercise or conversion : show line 6 in the form +35,364 $79.02 $2,794,463 187,467 D
2022-05-17 Exercise or conversion : show line 7 in the form +64,636 $93.50 $6,043,466 252,103 D
2022-05-17 Sale : show line 8 in the form −43,621 $153.43 $6,692,770 208,482 D
2022-05-17 Sale : show line 9 in the form −54,279 $154.49 $8,385,563 154,203 D
2022-05-17 Sale : show line 10 in the form −2,100 $155.27 $326,067 152,103 D
Open-market sales · 200,000 sh · avg $154.25 · $30,849,488

Table II: Derivative

4 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2022-05-16 Exercise or conversion : show line 11 in the form Option (Right to Buy) −70,879 $61.36 $4,349,135 $61.36 2027-02-15 70,879 0 D
2022-05-16 Exercise or conversion : show line 12 in the form Option (Right to Buy) −29,121 $79.20 $2,306,383 $79.02 2029-02-20 29,121 35,364 D
2022-05-17 Exercise or conversion : show line 13 in the form Option (Right to Buy) −35,364 $79.02 $2,794,463 $79.02 2029-02-20 35,364 0 D
2022-05-17 Exercise or conversion : show line 14 in the form Option (Right to Buy) −64,636 $93.50 $6,043,466 $93.50 2030-02-19 64,636 49,930 D
Loading xslF345X03/edgar.xml…